Epacadostat
-
Combination of Merck, Incyte Cancer Treatments Shows Promising Results
A new study combining the use of Merck’s Keytruda cancer treatment with Incyte’s immune-oncology drug Epacadostat, is showing promising results…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
